Design, rationale, and baseline characteristics of the Prospective Pravastatin Pooling (PPP) project—A combined analysis of three large-scale randomized trials: Long-Term Intervention With Pravastatin in Ischemic Disease (LIPID), Cholesterol and Recurrent Events (CARE), and West of Scotland Coronary Prevention Study (WOSCOPS)-Reference-Cited by-同舟云学术

Design, rationale, and baseline characteristics of the Prospective Pravastatin Pooling (PPP) project—A combined analysis of three large-scale randomized trials: Long-Term Intervention With Pravastatin in Ischemic Disease (LIPID), Cholesterol and Recurrent Events (CARE), and West of Scotland Coronary Prevention Study (WOSCOPS)

Published:1995-11 Issue:12 Volume:76 Page:899-905
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

The PPP Project Investigators

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. An analysis of randomized trials evaluating the effect of cholesterol reduction on total mortality and coronary heart disease incidence;Holme;Circulation,1990

2. Cholesterol-lowering trial results in their epidemiological context;Peto;Circulation,1985

3. The value of lowering cholesterol after myocardial infarction;Rossouw;N Engl J Med,1990

4. The Lipid Research Clinics Coronary Primary Prevention Trial I. Reduction in incidence of coronary heart disease;Lipid Research Clinics Program;JAMA,1984

5. Helsinki Heart Study: primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease;Frick;N Engl J Med,1987

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis;Cochrane Database of Systematic Reviews;2023-11-29

2. Wounds research for patient benefit: a 5-year programme of research;Programme Grants for Applied Research;2016-08

3. The efficacy and safety of statins for the treatment of non-alcoholic fatty liver disease;Digestive and Liver Disease;2015-01

4. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis;Cochrane Database of Systematic Reviews;2014-05-31

5. Analysis of combined data from heterogeneous study designs: an applied example from the patient navigation research program;Clinical Trials;2012-01-24